v3.25.4
Asset Acquisition and License Agreements - Schedule of Asset Acquisition (Details) - Chimerix
$ in Thousands
1 Months Ended
Apr. 30, 2025
USD ($)
Consideration  
Total cash consideration paid to Chimerix $ 944,154
Transaction costs 13,237
Total consideration 957,391
Cash 99,338
In-process research and development 905,362
Accrued liabilities (53,066)
Other assets and liabilities 5,757
Total net assets acquired 957,391
Outstanding Common Stock  
Consideration  
Total cash consideration paid to Chimerix 802,023
Outstanding Equity Awards  
Consideration  
Total cash consideration paid to Chimerix $ 142,131